Alpha Tau Medical Ltd.

NasdaqCM:DRTS Stock Report

Market Cap: US$160.5m

Alpha Tau Medical Management

Management criteria checks 4/4

Alpha Tau Medical's CEO is Uzi Sofer, appointed in Jan 2015, has a tenure of 9.83 years. total yearly compensation is $630.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 16.47% of the company’s shares, worth $26.43M. The average tenure of the management team and the board of directors is 5.8 years and 7.8 years respectively.

Key information

Uzi Sofer

Chief executive officer

US$630.0k

Total compensation

CEO salary percentage100.0%
CEO tenure9.8yrs
CEO ownership16.5%
Management average tenure5.8yrs
Board average tenure7.8yrs

Recent management updates

Recent updates

Alpha Tau Medical (NASDAQ:DRTS) Has Debt But No Earnings; Should You Worry?

May 25
Alpha Tau Medical (NASDAQ:DRTS) Has Debt But No Earnings; Should You Worry?

Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans

Nov 08
Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans

Alpha Tau director gives up board seat to take up chief commercial officer role

Sep 02

Alpha Tau Medical GAAP EPS of -$0.03

Aug 25

Alpha Tau: Treating Cancer With Precision Alpha Radiation

Apr 12

CEO Compensation Analysis

How has Uzi Sofer's remuneration changed compared to Alpha Tau Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$30m

Jun 30 2024n/an/a

-US$28m

Mar 31 2024n/an/a

-US$29m

Dec 31 2023US$630kUS$630k

-US$29m

Sep 30 2023n/an/a

-US$25m

Jun 30 2023n/an/a

-US$23m

Mar 31 2023n/an/a

-US$16m

Dec 31 2022US$3mUS$628k

-US$34m

Compensation vs Market: Uzi's total compensation ($USD630.00K) is below average for companies of similar size in the US market ($USD1.47M).

Compensation vs Earnings: Uzi's compensation has been consistent with company performance over the past year.


CEO

Uzi Sofer (54 yo)

9.8yrs

Tenure

US$630,000

Compensation

Mr. Uzi Sofer serves as Chief Executive Officer and Chairman at Alpha Tau Medical LTD (Alternate name Healthcare Capital Corp.) since 2015. He founded Brainsway Ltd., in 2006 and served as its Chief Execut...


Leadership Team

NamePositionTenureCompensationOwnership
Uzi Sofer
CEO & Chairman9.8yrsUS$630.00k16.47%
$ 26.4m
Raphi Levy
Chief Financial Officer5.8yrsUS$424.00k0%
$ 0
Amnon Gat
Chief Operations Officer6.8yrsUS$340.00k0.098%
$ 157.2k
Peter Melnyk
Chief Commercial Officer2.2yrsUS$376.00k0%
$ 0
Robert Den
Chief Medical Officer & Member of Scientific Advisory Board5.2yrsUS$401.00k0%
$ 0
Ronen Segal
Chief Technology Officer5.8yrsUS$705.00k0%
$ 0
Yona Keisari
Chief Scientific Officer & Member of Scientific Advisory board5.2yrsno data0.72%
$ 1.2m
Rebecca Becker
Vice President of legalno datano datano data
Itzhak Kelson
Chief Physics Officer & Member of Scientific Advisory Board8.8yrsno data1.9%
$ 3.0m
Yael Zeiger
Corporate Controllerno datano datano data

5.8yrs

Average Tenure

51yo

Average Age

Experienced Management: DRTS's management team is seasoned and experienced (5.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Uzi Sofer
CEO & Chairman9.8yrsUS$630.00k16.47%
$ 26.4m
Robert Den
Chief Medical Officer & Member of Scientific Advisory Boardno dataUS$401.00k0%
$ 0
Yona Keisari
Chief Scientific Officer & Member of Scientific Advisory board5.2yrsno data0.72%
$ 1.2m
Itzhak Kelson
Chief Physics Officer & Member of Scientific Advisory Boardno datano data1.9%
$ 3.0m
Ruth Alon
Independent Director2.7yrsno data0%
$ 0
Alan Adler
Independent Director6.8yrsno data0%
$ 0
David Milch
Independent Director2.7yrsno data0.41%
$ 662.8k
Meir Jakobsohn
Independent Director8.8yrsno data0.11%
$ 172.1k
Michael Zelefsky
Member of Scientific Advisory Boardno datano datano data
S. Blumenfeld
Independent Director8.8yrsno data0.067%
$ 108.1k
Michael Avruch
Director8.8yrsno data2.17%
$ 3.5m
Aron Popovtzer
Member of Scientific Advisory Boardno datano datano data

7.8yrs

Average Tenure

70yo

Average Age

Experienced Board: DRTS's board of directors are considered experienced (7.8 years average tenure).